Access To Medicines Foundation Details Methodology For 2018 AMR Benchmark 24/08/2017 by Intellectual Property Watch Leave a Comment The Amsterdam-based Access to Medicines Foundation today published the methodology it will use for its 2018 framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance, addressing the rising the global problem of overuse of antibiotics leading to resistance with few new ones in the pipeline.
US Issues Spate Of Trade Announcements, With IP In The Foreground 22/08/2017 by William New, Intellectual Property Watch Leave a Comment With much of the rest of the western world on holidays, the Office of the United States Trade Representative spent this month in meetings and issuing statements about improving international trade conditions for the US. Over the past two weeks, United States Trade Representative Robert Lighthizer and other senior officials have been involved in activities with Canada and Mexico (under renegotiation of the 1994 North American Free Trade Agreement, NAFTA), Japan, South Korea, and China.
India Grants Pfizer Patent On Pneumonia Vaccine, Stokes Fear Of Unaffordability 22/08/2017 by Intellectual Property Watch Leave a Comment MUMBAI (Reuters) – India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.
South Africa Government Completes IP Policy, Plans To Publish It This Month 08/08/2017 by Linda Daniels for Intellectual Property Watch 1 Comment CAPE TOWN — The Department of Trade and Industry (DTI) in South Africa has confirmed that the long-awaited national draft IP policy will be published in the Government Gazette this month. This comes after Cabinet approved the draft IP policy at its latest meeting last week.
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 by William New, Intellectual Property Watch Leave a Comment A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases.
New Book Puts WIPO Traditional Knowledge Committee In Perspective 02/08/2017 by William New, Intellectual Property Watch Leave a Comment A new book with contributions from key thinkers on the subject details the long history and intensive negotiations of the World Intellectual Property Organization committee on genetic resources, traditional knowledge and folklore, making a case for conclusion of binding international agreements in these areas as a way to close gaps in intellectual property policy.
Troubled Federal Circuit Hobbles US Patent System 31/07/2017 by Steven Seidenberg for Intellectual Property Watch Leave a Comment It’s been another dismal term for the Federal Circuit Court of Appeals. Six of its patent law decisions were reviewed in the US Supreme Court’s 2016-17 term, and the Federal Circuit’s decisions were overturned in all six cases. That, unfortunately, is not surprising. Over the past 15 years, the tribunal once known as the nation’s “patent court” has seen many of its most important patent law decisions reversed by the Supreme Court– sometimes in withering opinions. This has seriously undermined the Federal Circuit’s power, reputation, jurisprudence, and (apparently) self-confidence – causing a major problem for the United States’ patent system.
Report From WHO Fair Pricing Meeting Shows Balanced Discussion 28/07/2017 by William New, Intellectual Property Watch Leave a Comment A wide range of governments and stakeholders attended a closed meeting in the Netherlands in May to address the ongoing problem of pricing medicines to pay for research and the resulting lack of affordability of those medicines. The report from the World Health Organization-led meeting shows a range of points were made by participants and signals a move to change the global policy.
Companies Prefer Trade Secrets To Patents To Protect Innovation, EUIPO Finds 27/07/2017 by Dugie Standeford for Intellectual Property Watch 1 Comment “Despite their economic importance, and in particular their role in protecting returns from innovation, trade secrets are poorly studied and their relationship with patents is often misinterpreted,” the EU Intellectual Property Office (EUIPO) said in a study published this month. It used a survey of around 200,000 companies in Europe’s manufacturing and service industries to determine what factors influenced their choice between patents and trade secrets, as well as their overall use of both mechanisms. The results could help policy-makers, the Office said. It also holds out opportunities for innovative lawyers and intellectual property firms, said one IP management consultant.
US, European Views On IP Management And Digital Business 25/07/2017 by Guest contributor for Intellectual Property Watch Leave a Comment Data-driven technologies are enabling the expansion of trade and data flows around the world. We have disruptive smart products, smart industrial processes, smart clouds and smart services. Traditional industries such as pharmaceuticals, chemical and mechanical engineering digitally transform production processes to generate custom-tailored services and improve competitiveness using artificial intelligence while new companies emerge with disruptive offers. Such artificial intelligence-based business models, however, are bringing about a rethinking in European regulations in relation to copyrights, such as that deployed by DeepMind and Pinterest, for instance, because machine learning may reproduce countless amounts of proprietary content to generate raw solutions. A recent event in Paris delved into these and other issues, including data ownership and access rights, as well as inventions by computers.